Seeking Alpha

Sanofi, Shire interested in ViroPharma: Bloomberg

  • Details emerge on a possible ViroPharma (VPHM +27.4%) sale after Bloomberg initially reported the firm had hired Goldman to help it evaluate its options.
  • Citing sources, Bloomberg identifies Sanofi (SNY +0.1%) and Shire (SHPG +1.1%) as the interested parties.
  • Meanwhile, the Street is busy trying to nail the valuation.
  • Mark Deutsche down for $46-52/share.
  • More on the prospective deal here
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: